AIM ImmunoTech Inc
ASE:AIM 1:03:11 PM EDT
Earnings Announcements
Aim Immunotech Reports Fourth Quarter And Full Year 2021 Financial Results And Provides Corporate Update
Published: 03/31/2022 20:57 GMT
AIM ImmunoTech Inc (AIM) - Aim Immunotech Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update.
Revenue is expected to be $0.14 Million
Adjusted EPS is expected to be -$0.08
Next Quarter Revenue Guidance is expected to be $0.15 Million
Next Quarter EPS Guidance is expected to be -$0.08
More details on our Analysts Page.
Adjusted EPS is expected to be -$0.08
Next Quarter Revenue Guidance is expected to be $0.15 Million
Next Quarter EPS Guidance is expected to be -$0.08
More details on our Analysts Page.